These sustained encouraging results have been made possible with the Centre-led proactive and calibrated strategy of test, track, treat technology, the ministry underlined
A medical worker inoculates a woman with a COVID-19 vaccine at the Civil hospital in Amritsar on Wednesday. Pic/AFP
The daily COVID-19 recovered cases in India have been surpassing daily new cases from the last 20 days, while the total active cases stand at 1,76,498 comprising just 1.65 per cent of the total infections, the Union Health Ministry said on Wednesday. The cumulative recoveries have surged to 1,03,59,305 with 13,320 patients being discharged in a span of 24 hours. A total of 12,689 daily new cases were added to the national tally during the same period. “India has one of the lowest daily COVID-19 new cases Per Million Population (69) in the last seven days,” the ministry highlighted.
ADVERTISEMENT
These sustained encouraging results have been made possible with the Centre-led proactive and calibrated strategy of test, track, treat technology, the ministry underlined. Early identification through high and aggressive testing, prompt surveillance and tracking, supervised home isolation combined with high quality medical care through Standard of Care protocol issued by the Centre have aided the sustained high number of recoveries, it stated. The Union government has supported the state and UT governments with sufficient quantity of ventilators, PPE kits, drugs, etc, said the ministry.
‘Covaxin can neutralise the new UK strain’
Covaxin, developed by Bharat Biotech, has the ability to neutralise the UK variant of the Coronavirus, according to a preprint review by bioRxiv, a free online archive and distribution service for unpublished preprints in the life sciences. The archives is operated by Cold Spring Harbor Laboratory, a not-for-profit research and educational institution in New York.
‘Sri Lanka to buy 3 million doses of vaccine from India’
Sri Lanka will purchase 2 to 3 million doses of Oxford-AstraZeneca vaccine from its Indian manufacturing company Serum Institute of India during the next two days, a top Sri Lankan official said. Lalith Weeratunga, advisor to President Gotabaya Rajapaksa said that purchasing from India will follow Thursday’s arrival of India’s free vaccines. He said the Covishield vaccine is to arrive tomorrow and the consignment will be accepted by President Rajapaksa.